Clinical Trial Update: Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

View source ↗

Summary

A recruiting clinical trial aims to predict progression to multiple myeloma in high-risk screened individuals and the general population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Healthy | Status: RECRUITING